Parmax Pharma

Parmax Pharma FCF per Share

The Free Cash Flow per Share of Parmax Pharma (540359.BO) as of Oct 24, 2026 is -4.43 INR. In the previous year, Free Cash Flow per Share was -4.75 INR — a change of -6.65% (higher).

FCF per Share

-4.43INR

YoY

-6.65%

Last updated:

Free Cash Flow per Share of Parmax Pharma is 2025 -4.43 INR. Free Cash Flow per Share of Parmax Pharma was 2024 -4.75 INR. It decreases by -6.65% higher compared to the previous year.

The Parmax Pharma FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2023
-1.62 INR
Jan 1, 2024
-4.75 INR
Jan 1, 2025
-4.43 INR
The Parmax Pharma FCF per Share history
YEARFCF per ShareYoY
-4.43INR-6.65%
-4.75INR+192.61%
-1.62INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Parmax Pharma Stock analysis

What does Parmax Pharma do? Parmax Pharma Ltd is a pharmaceutical company based in Rajkot, India. The company completed its initial public offering (IPO) on March 16, 2017. It operates within the pharmaceutical sector, though specific details about its products, services, or market focus are not provided. The company's headquarters are located in Rajkot, Gujarat, and it maintains a corporate website at www.parmaxpharma.com. Parmax Pharma Ltd is listed on the Bombay Stock Exchange under the ticker symbol 540359.BO, with an ISIN code of INE240T01014. The company's sector and industry classifications are listed as N/A in available records, indicating a lack of detailed categorization in public sources. No information is provided regarding the company's founding year, key personnel, major acquisitions, or financial figures beyond the IPO date and listing details. The website serves as the primary source for company information, though the content is not elaborated upon in the provided data. Parmax Pharma Ltd is part of the Indian pharmaceutical industry, which is known for its focus on generic drugs and healthcare solutions. However, specific operational details about the company's manufacturing capabilities, product portfolio, or market reach remain unspecified in the available information. Parmax Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parmax Pharma stock

Free Cash Flow per Share of Parmax Pharma is -4.43 INR in 2025.

Free Cash Flow per Share of Parmax Pharma changed from -4.75 INR to -4.43 INR, representing a -6.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Parmax Pharma since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Parmax Pharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Parmax Pharma